Dr. McNally is a surgical oncologist specializing in colorectal cancers and complex malignancies. Graduating from the University of Missouri-Kansas City's BLA-MD program in 2005, she completed her general surgery residency at Truman Medical Centers and Saint Luke's Hospital in 2010, followed by fellowship training in surgical oncology. Board-certified by the American Board of Surgery and a fellow of the Society of Surgical Oncology, Dr. McNally earned a Master's in Medical Science from The Ohio State University, focusing on bioinformatic approaches to cholangiocarcinoma. She joined Saint Luke's Health System in 2012.

Dr. Ian Maher is a Professor and Director of Dermatology at the University of Minnesota. He specializes in Mohs surgery, and is board-certified by the American Board of Dermatology. Dr. Maher is also the Mohs Fellowship Director and focuses on teaching and clinical practice.

Dr. Jon Stuart Hourigan, MD, FACS, FASCRS was born and raised in Bowling Green, Kentucky. Dr. Hourigan’s clinical interests include the comprehensive treatment of colon cancer and rectal cancer, surgical management of inflammatory bowel disease and diverticulitis, and the treatment of benign anorectal disorders. He is an expert in both traditional and minimally invasive approaches for colon and rectal diseases.

Dr. Thanh Dellinger, MD, is a gynecologic oncologist with specialized training in robotic-assisted (minimally invasive) surgery for uterine and cervical cancer, which can be as effective as traditional surgery but with reduced scarring, pain and recovery time. Dr. Dellinger is also an expert in advanced cytoreductive surgery for ovarian cancer, which can significantly improve survival outcomes for patients. Additionally, Dr. Dellinger has specialized training in PIPAC, a novel drug delivery method for recurrent ovarian cancer patients.

Dr. Mohammed Dany, MD is the director of Mohs and dermatologic surgery at VCU Health in Richmond, VA. Dany is one of only a handful of Mohs surgeons in the greater Richmond area. In addition to Mohs surgery, Dany is also a cutaneous oncologist, treating patients with rare tumors such as Merkle cell carcinoma, sebaceous carcinoma and Dermatofibrosarcoma protuberans.

Dr. Vitaly Margulis, MD, Professor of Urology at UT Southwestern Medical Center, graduated with honors from the University of Texas at Austin and UT Southwestern Medical School. He trained in the highly competitive urology residency program at UT Southwestern and completed a fellowship in urologic oncology at the University of Texas MD Anderson Cancer Center in Houston, where he was previously a Clinical Specialist in Urologic Oncology. An expert surgeon, Dr. Margulis uses minimally invasive techniques to treat patients with soft-tissue tumors and kidney, prostate, bladder, testicular, penile, and adrenal cancers.

Nahid Y. Vidal, M.D., FAAD, FACMS, is a Mohs surgeon with subspecialty expertise in skin cancer treatment and complex reconstruction. Dr. Vidal is also a principal investigator for several clinical studies pertaining to skin cancer and dermatologic surgery, with special interests including rare and complex cutaneous tumors, immunohistochemistry for Mohs surgery, innovation in education, and artificial intelligence.

Dr. Robert Caleb Kovell, MD is a board-certified urologist focused on providing individualized care for patients while helping them understand their options and achieve their goals. His practice, at Penn Medicine in Philadelphia, focuses on reconstructive urology which includes improving urologic function when it has been compromised by trauma, congenital urologic conditions, cancer, previous surgery or radiation therapy.

Dr. Philip Iorianni, MD is a board-certified plastic surgeon working with the Mid-Atlantic Permanente Medical Group based in Kensington, Maryland. Dr. Iorianni received his medical education from the George Washington University School of Medicine and Health Sciences in Washington, DC.

Dr. Philippe Spiess is a genitourinary oncologist and the assistant chief of surgical services at the Moffitt Cancer Center. He is well a full professor of oncology and urology at the University of South Florida Morsani College of Medicine. Prior to joining Moffitt, Dr. Spiess completed a three-year SUO-accredited urologic oncology fellowship at the MD Anderson Cancer Center in Houston, TX.

Min Deng, MD, is the Director of Mohs Micrographic Surgery at MedStar Washington Hospital Center/MedStar Georgetown University Hospital and the only Mohs surgeon employed by MedStar Health. As a board-certified dermatologist and fellowship-trained Mohs surgeon, Dr. Deng has subspecialty expertise in cutaneous oncology, including the diagnosis and management of the most prevalent skin cancers.

Brandon T. Beal, MD is a Board-Certified Dermatologist, and Fellowship trained Mohs Micrographic Surgeon, dermatologic oncologist (cancer doctor of the skin), and facial reconstructive surgeon Dr. Beal completed his dermatology residency at the Cleveland Clinic Dermatology & Plastic Surgery Institute and his fellowship in Mohs Micrographic Surgery, dermatologic oncology, and facial reconstructive surgery at Zitelli & Brodland, PC.

Dr. Ramin Fathi, MD graduated from Illinois Wesleyan University in Bloomington, IL, with a degree in accounting. He then received his medical degree at Rush Medical College in Chicago, IL where he graduated at the top of his medical school class and was inducted into the Alpha Omega Alpha Honor Society. Dr. Fathi is board-certified by the American Board of Dermatology and is an Associate Member of the American College of Mohs Surgery.

Dr. Catherine Harrell is a board-certified dermatologist with extensive training in medical dermatology, cutaneous oncology, dermatologic surgery, and cosmetic dermatology. Dr. Harrell has a special interest in complex medical dermatology, bullous skin disorders, psoriasis and treatment of skin cancer.

Dr. Anthony M. Rossi, MD is a board certified dermatologist with fellowship training in Mohs Micrographic Surgery and advanced cutaneous oncology at the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College program. Dr. Rossi treats skin cancers as well as benign skin conditions. Dr. Rossi has specialized training and expertise in dermoscopy and other non-invasive methods of imaging.

Dr. Bryan Voelzke, MD, MS, FACS, is a board certified urologist at Spokane Urology. Dr. Voelzke prior academic practice was solely devoted to reconstructive urology at the University of Washington/Harborview Medical Center in Seattle. Dr. Voelzke has received a number of awards from patients in recognition of his attention to patient care.

Brad Figler received his medical degree from Case Western Reserve University School of Medicine and completed his residency training in Urology at Emory University Hospital in Atlanta, GA. After his fellowship training, Dr. Figler worked at Thomas Jefferson University in Philadelphia as Assistant Professor of Urology and Director of Reconstructive Urology. Dr. Figler serves as fellowship faculty for the UNC Urology Men's Health Fellowship.

Dr. Bradley Merritt, MD is a Dermatologist and Mohs surgeon in Chapel Hill, North Carolina. Dr. Merritt and is highly rated for his expertise skin cancers, including extramammary Paget’s disease (EMPD), and reconstructive urology surgery. Dr. Merritt is an Associate Professor and Clinical Researcher in Dermatology, at University of North Carolina (UNC-Chapel Hill).

Dr. Sophie Dessureault is a surgical oncologist in the Department of Gastrointestinal Oncology at Moffitt Cancer Center. She is a professor of oncology and surgery at the University of South Florida Morsani College of Medicine. Dr. Dessureault is widely published and is a member of numerous professional organizations.

Dr. Paul Chung is a Jefferson University urology physician with experience in genitourinary reconstruction and extramammary Paget's disease (EMPD) treatment in men. Dr. Chung is a Sidney Kimmel Medical College, at Thomas Jefferson University Medical School, graduate. Dr. Chung had an internship and residency at University of Texas Southwestern and a fellowship at University of Washington in Seattle, WA.

Dr. Joseph Ivy is dedicated to providing compassionate, effective care for female cancer patients and their families. He passionately believes that cancer care should focus on providing the best possible quality of life and chance of recovery for his patients. Dr. Ivy uses minimally invasive techniques whenever possible in his surgical practice.

Dr. Janiel Cragun is an Assistant Professor in the Department of Obstetrics and Gynecology at the University of Arizona. She is fellowship-trained in the specialty of gynecology oncology. Dr. Cragun offers surgical interventions to include both radical and minimally invasive procedures. She also offers chemotherapeutic and palliative interventions.

Gynecologist-obstetrician, Dr. Patrice Mathevet is an expert in gynecological cancers and more particularly in the surgical treatment of pelvic cancers. He was appointed full professor of UNIL and chief physician of the Department of Gynecology of CHUV from 1 October 2013.

Tyler Ford, MD, is a gynecologic oncologist in Richmond, VA. Dr. Ford earned his medical degree from Albany Medical College and completed a residency in obstetrics and gynecology at Albany Medical Center in Albany, NY. Dr. Ford’s specialties include minimally-invasive surgical techniques treating specific gynecologic cancers, as well as clinical research.

The research involvement and interests of Dr. Jamie N. Bakkum-Gamez, MD, include screening and early detection modalities in ovarian cancer and endometrial cancer; prognostic molecular markers in ovarian cancer and endometrial cancer; and quality improvement in postoperative outcomes after ovarian cancer staging surgery.

Dr. Curtis Pettaway is an urologist in Houston, Texas and is affiliated with University of Texas MD Anderson Cancer Center. He received his medical degree from Temple University School of Medicine and has been in practice for more than 20 years. Dr. Pettaway is one of 18 doctors at University of Texas MD Anderson Cancer Center who specialize in Urology.

Dr. Otley is professor and chair of the department of dermatology at Mayo Clinic in Rochester, MN. He majored in religion at Williams College, received his medical degree at Duke University, completed a residency in dermatology at Harvard University and then a fellowship in Mohs and Dermatologic Surgery at Mayo Clinic.

Dr. Sumaira Z. Aasi, M.D., is a Professor of Dermatology and Director of Mohs and Dermatologic Surgery. Dr. Aasi completed a fellowship in Mohs micrographic surgery and cutaneous oncology at Yale University where she was on faculty and served as Associate Chief. Dr. Aasi clinical interests include management of high risk nonmelanoma skin cancers, Mohs histopathology, and reconstructive surgery.

Dr. Alexander R. Miller is an experienced surgical oncologist specializing in breast cancer, skin cancer (melanoma), pancreatic and gastric cancer, as well as sarcoma. He has devoted his career to cancer research, education and treatment.

Assistant Professor, Section of Mohs and dermasuregery, Department of Dermatology, Division of Internal Medicine, University of Texas M.D. Anderson Cancer Center, Houston, TX.